Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Konstantinos Arnaoutakis

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Arnaoutakis, Konstantinos

PropertyValue
overview Dr. Konstantinos Arnaoutakis is a hematologist and oncologist at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences. He is also an Associate Professor in the Department of Internal Medicine, Division of Hematology and Oncology. Dr. Arnaoutakis received his medical degree from the University of Patras Medical School in Greece. He served an internal medicine residency at Albany Medical College-Albany Medical Center Hospital. He also served a fellowship in hematology and oncology at Tufts University, St. Elizabeth's Medical Center in Boston, MA. He later went on to serve as Chief Hematology and Medical Oncology Fellow at Tufts University. He is board certified in internal medicine, hematology and oncology. He is a member of the American Medical Association, American College of Physician, American Society of Clinical Oncology and American Society of Hematology. His primary research interests are lung cancer, head and neck cancer and genitourinary cancers.

One or more keywords matched the following items that are connected to Arnaoutakis, Konstantinos

Item TypeName
Academic Article Lung cancer in octogenarians.
Academic Article Paralyzed by a rare cause: an unusual case of metastatic diffuse large B cell lymphoma of the intramedullary spinal cord.
Academic Article Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.
Academic Article Bronchus-associated lymphoid tissue lymphomas.
Concept Breast Neoplasms
Concept Bronchial Neoplasms
Concept Spinal Cord Neoplasms
Concept Testicular Neoplasms
Concept Bone Marrow Neoplasms
Concept Lung Neoplasms
Concept Kidney Neoplasms
Concept Neoplasms
Academic Article Primary bone marrow Hodgkin lymphoma in an HIV-negative patient.
Academic Article Use of a standardized web-based tool for evaluation of aromatase inhibitor related bone loss in breast cancer patients
Academic Article Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer
Academic Article The role of salvage hemiscrotectomy in testicular cancer after scrotal contamination: a case report and literature review.
Academic Article Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer.
Academic Article Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Academic Article Molecular Markers in the Diagnosis and Treatment of Cancer.
Academic Article Simulating Four Essential Conversations with Hematology/Oncology Trainees: a Qualitative Evaluation.
Academic Article Metastatic Renal Cell Carcinoma Presenting as Painful Chewing Successfully Treated with Combined Nivolumab and Sunitinib.
Academic Article Improving Communication on Intent of Chemotherapy Using QOPI Scores and PDSA Cycles.
Academic Article Integrating Collaborative Learning and Competition in a Hematology/Oncology Training Program.
Academic Article Hyalinizing Clear Cell Carcinoma of the Lung: Case Report and Review of the Literature.
Academic Article Targeting nano drug delivery to cancer cells using tunable, multi-layer, silver-decorated gold nanorods.
Academic Article Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Academic Article Cancer patient perspectives regarding preparedness for end-of-life care: A qualitative study.
Academic Article PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin.
Academic Article A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant.
Grant Scientific and methodological advancement in liquid biopsies to further the development of lung cancer-based precision medicine
Grant A Randomized, Controlled Phase III Study Investigating IMA901 Multipeptide Cancer Vaccine in Patients receiving Sunitinib as First-Line Therapy for Ad
Grant A Phase III Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel with or without the PARP Inhibitor Verliparib (ABT-888) in Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
Grant Scientific and methodological advancement in liquid biopsies to further the development of lung cancer-based precision medicine
Grant PHASE 3 Study EVAL EFFICACY AND SAFETY OF MPDL32 80A (IN COMBINATION W CARBOPLATIN+PACLITAXEL OR MPDL3280A IN COMBO W CARBO+NAB -PACLITAXEL VERSUS CARBO+NAB-PACLITAXEL IN CHEMO-NAÏVE PTS W STAGE 4 SQUAMOUS NON SMALL CELL LUNG CANCER
Grant Phase 2, Open-Label Single Arm Study of the Efficacy and Safety of PF-02341066 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Echino
Academic Article Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed EGFR Mutant Non-Small-Cell Lung Cancer.
Grant LUNGMAP - A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study) (IRB 239473)
Grant S1900C: A Phase II Study of Talazoparib Plus Avelumab in Patients with Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer Bearing Pathogenic STK11 Genomic Alterations (LUNG-MAP Sub-Study) (260760)
Grant S1900B: A Phase II Study of LOXO-292 in Patients with RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study) (260759)
Academic Article Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench.
Grant A Phase III Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel with or without the PARP Inhibitor Verliparib (ABT-888) in Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
Grant S1929, Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC) (273385)
Grant A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Tarlatamabin Subjects with Relapsed/Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment (DeLLphi-301)
Grant A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Tarlatamabin Subjects with Relapsed/Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment (DeLLphi-301)
Academic Article Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care.

Search Criteria
  • Cancers